These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30980441)

  • 1. Impact of anticoagulation therapy on outcomes in patients with cardiac implantable resynchronization devices undergoing transvenous lead extraction: A substudy of the ESC-EHRA EORP ELECTRa (European Lead Extraction ConTRolled) Registry.
    Regoli F; Auricchio A; Di Cori A; Segreti L; Blomström-Lunqvist C; Butter C; Deharo JC; Kennergren C; Kutarski A; Laroche C; Zalevskiy V; Luzzi G; Cano O; Grabowski M; Rinaldi C; Bongiorni MG
    J Cardiovasc Electrophysiol; 2019 Jul; 30(7):1086-1095. PubMed ID: 30980441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical impact of antithrombotic therapy in transvenous lead extraction complications: a sub-analysis from the ESC-EORP EHRA ELECTRa (European Lead Extraction ConTRolled) Registry.
    Di Cori A; Auricchio A; Regoli F; Blomström-Lundqvist C; Butter C; Dagres N; Deharo JC; Maggioni AP; Kutarski A; Kennergren C; Laroche C; Rinaldi CA; Dovellini EV; Golzio PG; Thøgersen AM; Bongiorni MG;
    Europace; 2019 Jul; 21(7):1096-1105. PubMed ID: 31505593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transvenous lead extraction procedures in women based on ESC-EHRA EORP European Lead Extraction ConTRolled ELECTRa registry: is female sex a predictor of complications?
    Polewczyk A; Rinaldi CA; Sohal M; Golzio PG; Claridge S; Cano O; Laroche C; Kennergren C; Deharo JC; Kutarski A; Butter C; Blomström-Lundqvist C; Romano SL; Maggioni AP; Auricchio A; Diemberger I; Pisano ECL; Rossillo A; Kuck KH; Forster T; Bongiorni MG;
    Europace; 2019 Dec; 21(12):1890-1899. PubMed ID: 31665280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High recurrence of device-related adverse events following transvenous lead extraction procedure in patients with cardiac resynchronization devices.
    Regoli F; Bongiorni MG; Rordorf R; Santamaria M; Klersy C; Segreti L; De Regibus V; Moccetti T; Conte G; Caputo ML; Auricchio A
    Eur J Heart Fail; 2016 Oct; 18(10):1270-1277. PubMed ID: 27170594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of outcomes in infected cardiovascular implantable electronic devices between complete, partial, and failed lead removal: an ESC-EHRA-EORP ELECTRa (European Lead Extraction ConTrolled) registry.
    Nof E; Bongiorni MG; Auricchio A; Butter C; Dagres N; Deharo JC; Rinaldi CA; Maggioni AP; Kutarski A; Kennergren C; Laroche C; Milman A; Beinart R; Bogdan S; Mortsell D; Calvi V; Desiron Q; Mansourati J; Blomstrom Lundqvist C; Glikson M;
    Europace; 2019 Dec; 21(12):1876-1889. PubMed ID: 31625553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procedural outcomes associated with transvenous lead extraction in patients with abandoned leads: an ESC-EHRA ELECTRa (European Lead Extraction ConTRolled) Registry Sub-Analysis.
    Segreti L; Rinaldi CA; Claridge S; Svendsen JH; Blomstrom-Lundqvist C; Auricchio A; Butter C; Dagres N; Deharo JC; Maggioni AP; Kutarski A; Kennergren C; Laroche C; Kempa M; Magnani A; Casteigt B; Bongiorni MG;
    Europace; 2019 Apr; 21(4):645-654. PubMed ID: 30624715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The European Lead Extraction ConTRolled (ELECTRa) study: a European Heart Rhythm Association (EHRA) Registry of Transvenous Lead Extraction Outcomes.
    Bongiorni MG; Kennergren C; Butter C; Deharo JC; Kutarski A; Rinaldi CA; Romano SL; Maggioni AP; Andarala M; Auricchio A; Kuck KH; Blomström-Lundqvist C;
    Eur Heart J; 2017 Oct; 38(40):2995-3005. PubMed ID: 28369414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lead extraction: The road to successful cardiac resynchronization therapy.
    Maciąg A; Syska P; Sterliński M; Przybylski A; Sitkowska E; Oręziak A; Bilińska M; Kuśmierczyk M; Szwed H
    Cardiol J; 2015; 22(2):188-93. PubMed ID: 25299498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial.
    Lenarczyk R; Kowalski O; Sredniawa B; Pruszkowska-Skrzep P; Mazurek M; Jędrzejczyk-Patej E; Woźniak A; Pluta S; Głowacki J; Kalarus Z
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1228-36. PubMed ID: 22651239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major cardiac and vascular complications after transvenous lead extraction: acute outcome and predictive factors from the ESC-EHRA ELECTRa (European Lead Extraction ConTRolled) registry.
    Zucchelli G; Di Cori A; Segreti L; Laroche C; Blomstrom-Lundqvist C; Kutarski A; Regoli F; Butter C; Defaye P; Pasquié JL; Auricchio A; Maggioni AP; Bongiorni MG;
    Europace; 2019 May; 21(5):771-780. PubMed ID: 30590520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transvenous lead extraction in patients with cardiac resynchronization therapy devices is not associated with increased 30-day mortality.
    Gould J; Klis M; Porter B; Sieniewicz BJ; Sidhu BS; Claridge S; Williams SE; Shetty A; O'Neill M; Gill J; Rinaldi CA
    Europace; 2019 Jun; 21(6):928-936. PubMed ID: 30590509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of centre volume and procedure location on major complications and mortality from transvenous lead extraction: an ESC EHRA EORP European Lead Extraction ConTRolled ELECTRa registry subanalysis.
    Sidhu BS; Gould J; Bunce C; Elliott M; Mehta V; Kennergren C; Butter C; Deharo JC; Kutarski A; Maggioni AP; Auricchio A; Kuck KH; Blomström-Lundqvist C; Bongiorni MG; Rinaldi CA;
    Europace; 2020 Nov; 22(11):1718-1728. PubMed ID: 32688392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complications in recipients of cardioverter-defibrillator or cardiac resynchronization therapy: Insights from Silesian Center Defibrillator registry.
    Tajstra M; Gadula-Gacek E; Kurek A; Adamowicz-Czoch E; Olszowski D; Ostręga M; Ciślak A; Pyka Ł; Hawranek M; Lekston A; Poloński L; Gąsior M
    Cardiol J; 2017; 24(5):515-522. PubMed ID: 27734455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk stratification of patients undergoing transvenous lead extraction with the ELECTRa Registry Outcome Score (EROS): an ESC EHRA EORP European lead extraction ConTRolled ELECTRa registry analysis.
    Sidhu BS; Ayis S; Gould J; Elliott MK; Mehta V; Kennergren C; Butter C; Deharo JC; Kutarski A; Maggioni AP; Auricchio A; Kuck KH; Blomström-Lundqvist C; Bongiorni MG; Rinaldi CA;
    Europace; 2021 Sep; 23(9):1462-1471. PubMed ID: 33615342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The European Society of Cardiology Cardiac Resynchronization Therapy Survey II: A comparison of cardiac resynchronization therapy implantation practice in Europe and France.
    Galand V; Linde C; Lellouche N; Mansourati J; Deharo JC; Sagnol P; Da Costa A; Horvilleur J; Defaye P; Boveda S; Steinbach M; Bru P; Rumeau P; Beard T; Younsi S; Dickstein K; Normand C; Leclercq C
    Arch Cardiovasc Dis; 2019 Nov; 112(11):713-722. PubMed ID: 31706879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, predictors, and procedural results of upgrade to resynchronization therapy: the RAFT upgrade substudy.
    Essebag V; Joza J; Birnie DH; Sapp JL; Sterns LD; Philippon F; Yee R; Crystal E; Kus T; Rinne C; Healey JS; Sami M; Thibault B; Exner DV; Coutu B; Simpson CS; Wulffhart Z; Yetisir E; Wells G; Tang AS
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):152-8. PubMed ID: 25417892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amiodarone is associated with adverse outcomes in patients with sustained ventricular arrhythmias upgraded to cardiac resynchronization therapy-defibrillators.
    Adelstein EC; Althouse AD; Davis L; Schwartzman D; Bazaz R; Jain S; Wang N; Saba S
    J Cardiovasc Electrophysiol; 2019 Mar; 30(3):348-356. PubMed ID: 30575185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Effectiveness of Transvenous Lead Extraction in Patients with Infected Cardiac Resynchronization Therapy Devices; Is It More Risky than Extraction of Other Systems?
    Stefańczyk P; Nowosielecka D; Polewczyk A; Tułecki Ł; Tomków K; Jacheć W; Lewicka E; Tomaszewski A; Kutarski A
    Int J Environ Res Public Health; 2022 May; 19(10):. PubMed ID: 35627340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ELECTRa (European Lead Extraction ConTRolled) Registry--shedding light on transvenous lead extraction real-world practice in Europe.
    Bongiorni MG; Romano SL; Kennergren C; Butter C; Deharo JC; Kutarsky A; Rinaldi CA; Maggioni AP; Blomström-Lundqvist C; Auricchio A
    Herzschrittmacherther Elektrophysiol; 2013 Sep; 24(3):171-5. PubMed ID: 23942611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine learning-derived major adverse event prediction of patients undergoing transvenous lead extraction: Using the ESC EHRA EORP European lead extraction ConTRolled ELECTRa registry.
    Mehta VS; O'Brien H; Elliott MK; Wijesuriya N; Auricchio A; Ayis S; Blomstrom-Lundqvist C; Bongiorni MG; Butter C; Deharo JC; Gould J; Kennergren C; Kuck KH; Kutarski A; Leclercq C; Maggioni AP; Sidhu BS; Wong T; Niederer S; Rinaldi CA;
    Heart Rhythm; 2022 Jun; 19(6):885-893. PubMed ID: 35490083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.